Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism.
about
Molecular pathophysiology of priapism: emerging targetsEndothelin-1 but not Endothelial Nitric Oxide Synthase Gene Polymorphism is Associated with Sickle Cell Disease in AfricaRandomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease.Opiorphin is a master regulator of the hypoxic response in corporal smooth muscle cells.Opiorphin-dependent upregulation of CD73 (a key enzyme in the adenosine signaling pathway) in corporal smooth muscle cells exposed to hypoxic conditions and in corporal tissue in pre-priapic sickle cell mice.Overactive bladder in adults with sickle cell disease.Transnitrosylation: A Factor in Nitric Oxide-Mediated Penile Erection.Two N-(2-phenylethyl)nitroaniline derivatives as precursors for slow and sustained nitric oxide release agents.Featured article: induction of heme oxygenase with hemin improves pericardial adipocyte morphology and function in obese Zucker rats by enhancing proteins of regeneration.Hydroxyurea therapy for priapism prevention and erectile function recovery in sickle cell disease: a case report and review of the literature.Nitrergic Mechanisms for Management of Recurrent PriapismDevelopment and therapeutic applications of nitric oxide releasing materials to treat erectile dysfunction.How I treat priapism.Advances in the understanding of priapism.Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: profile and risk factors.Beneficial Effect of the Nitric Oxide Donor Compound 3-(1,3-Dioxoisoindolin-2-yl)Benzyl Nitrate on Dysregulated Phosphodiesterase 5, NADPH Oxidase, and Nitrosative Stress in the Sickle Cell Mouse Penis: Implication for Priapism Treatment.Priapism in a Fabry disease mouse model is associated with upregulated penile nNOS and eNOS expression.
P2860
Q27010069-11B83336-333B-47AD-BA6D-D77E1B8F9C1DQ28387609-929E80E1-C814-484C-B6B5-72B234EC341FQ33859035-F6F8C34F-4971-454E-8C6D-23945D821AF4Q33913200-76B4F7FE-20C7-44AA-B4A8-71A6C63C0C8AQ35858706-04E03570-33D5-4E35-8D92-C8289F75978AQ36161766-54687FC9-8F88-4FC7-A540-6AC1D0BE3E32Q36848221-725598DB-BD14-445E-9BE3-F00B49D84540Q36871040-351BE1D2-95BC-44D1-BB8A-681DD4C293DEQ37070966-2C62E205-140B-435F-BEE5-A5774D44E9ECQ38211494-70707337-34CD-4A12-B783-B0353D329893Q38610620-9E54DBD6-D3B5-4654-A7A4-0A14928D2AE7Q38889467-497BC778-0A5D-4763-AADB-1D66B18D9600Q39025090-1ECEB890-D580-4431-8B1A-D6554C8BBAD2Q39327895-89CA2469-D73D-4385-BCA5-20DE805F5D79Q40852821-389ED4A6-5616-4D15-862A-C06496069831Q42713286-248B7EFC-846C-46B8-851D-4AF8247FD332Q47645407-89A6C89A-4B26-4965-98CC-105DB977DBE3
P2860
Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Sustained nitric oxide (NO)-re ...... gnal transduction in priapism.
@ast
Sustained nitric oxide (NO)-re ...... gnal transduction in priapism.
@en
type
label
Sustained nitric oxide (NO)-re ...... gnal transduction in priapism.
@ast
Sustained nitric oxide (NO)-re ...... gnal transduction in priapism.
@en
prefLabel
Sustained nitric oxide (NO)-re ...... gnal transduction in priapism.
@ast
Sustained nitric oxide (NO)-re ...... gnal transduction in priapism.
@en
P2093
P2860
P356
P1433
P1476
Sustained nitric oxide (NO)-re ...... gnal transduction in priapism.
@en
P2093
Arthur L Burnett
Dillip K Mohanty
Gwen Lagoda
Sena F Sezen
P2860
P356
10.1096/FJ.13-228817
P407
P577
2013-09-27T00:00:00Z